国家早期预警评分(NEWS)及其修订版NEWS2在SARS-CoV-2感染住院患者中的表现
该研究利用五个队列(COVID-19阳性405例、未检出1716例、未检测2686例、2018年对照6273例、2019年对照6523例)的受试者工作特征曲线下面积(AUROC),评估NEWS/NEWS2对24小时内死亡或ICU入院的联合结局的判别能力。结果显示各队列AUROC范围为0.842-0.894,COVID-19阳性队列为0.882(95%CI 0.868-0.895)。结论认为NEWS/NEWS2在COVID-19患者中表现良好且与其它队列相似,无需增加新协变量或调整现有参数权重,支持国家及国际指南推荐使用NEWS/NEWS2评估COVID-19患者急性疾病严重程度。
要点
- 在COVID-19阳性住院患者中,NEWS/NEWS2预测24小时内死亡或ICU入院的AUROC为0.882(95%CI 0.868-0.895)。
- 五个队列的AUROC范围为0.842-0.894,COVID-19队列与对照队列表现相似。
- 原文结论:无需为COVID-19患者修改NEWS/NEWS2(如增加新协变量或改变现有参数权重)。
- 结果支持国家及国际指南推荐使用NEWS/NEWS2评估COVID-19住院患者的急性疾病严重程度。
适用人群与场景
- 住院的COVID-19阳性患者(n=405),以及COVID-19未检出(n=1716)、未检测(n=2686)和2018年对照(n=6273)、2019年对照(n=6523)住院患者。
- 原文未提及排除人群、具体病房类型或病情阶段。
诊断标准与关键阈值
- 使用NEWS或NEWS2评分,以AUROC评估其对生命体征采集后24小时内死亡或ICU入院的联合结局的判别能力。
- 原文未提及NEWS/NEWS2的具体评分界值或触发阈值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及红旗征或不能漏诊的具体情况。
研究设计与关键结果
- 研究类型:回顾性队列分析(基于原文方法描述),五个队列,总样本量原文未汇总给出。
- 主要终点:NEWS/NEWS2预测24小时内死亡或ICU入院的AUROC:COVID-19阳性0.882(95%CI 0.868-0.895);COVID-19未检出0.875(95%CI 0.861-0.89);COVID-19未检测0.876(95%CI 0.85-0.902);2018年对照0.894(95%CI 0.884-0.904);2019年对照0.842(95%CI 0.829-0.855)。
- 关键次要终点及不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:回顾性队列研究(基于原文方法描述),原文未明确报告证据等级或推荐强度。
- 局限:原文未明确说明,但设计为多队列回顾性分析,各队列样本量不一,未提及前瞻性验证。
对床旁实践的改变
- 对于住院的COVID-19患者,可使用NEWS/NEWS2评估急性疾病严重程度,无需修改评分参数或增加新协变量。
- 原文未提及适用与不适用人群的具体排除标准,也未提及常见陷阱。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Since the introduction of the UK's National Early Warning Score (NEWS) and its modification, NEWS2, coronavirus disease 2019 (COVID-19), has caused a worldwide pandemic. NEWS and NEWS2 have good predictive abilities in patients with other infections and sepsis, however there is little evidence of their performance in COVID-19.
METHODS: Using receiver-operating characteristics analyses, we used the area under the receiver operating characteristic (AUROC) curve to evaluate the performance of NEWS or NEWS2 to discriminate the combined outcome of either death or intensive care unit (ICU) admission within 24 h of a vital sign set in five cohorts (COVID-19 POSITIVE, n = 405; COVID-19 NOT DETECTED, n = 1716; COVID-19 NOT TESTED, n = 2686; CONTROL 2018, n = 6273; CONTROL 2019, n = 6523).
RESULTS: The AUROC values for NEWS or NEWS2 for the combined outcome were: COVID-19 POSITIVE, 0.882 (0.868-0.895); COVID-19 NOT DETECTED, 0.875 (0.861-0.89); COVID-19 NOT TESTED, 0.876 (0.85-0.902); CONTROL 2018, 0.894 (0.884-0.904); CONTROL 2019, 0.842 (0.829-0.855).
CONCLUSIONS: The finding that NEWS or NEWS2 performance was good and similar in all five cohorts (range = 0.842-0.894) suggests that amendments to NEWS or NEWS2, such as the addition of new covariates or the need to change the weighting of existing parameters, are unnecessary when evaluating patients with COVID-19. Our results support the national and international recommendations for the use of NEWS or NEWS2 for the assessment of acute-illness severity in patients with COVID-19.
参考来源
- Kostakis I, Smith GB, Prytherch D, et al. The performance of the National Early Warning Score and National Early Warning Score 2 in hospitalised patients infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Resuscitation. 2020. PMID: 33176170. doi:10.1016/j.resuscitation.2020.10.039
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。